Smith MR, Egerdie B, Hernandez Toriz N, et al, Denosumab HALT Prostate Cancer Study Group. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009, 361(8):745
Advertisement
Articles by Smith MR, Egerdie B, Hernandez Toriz N, et al, Denosumab HALT Prostate Cancer Study Group. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med. 2009, 361(8):745
Advertisement
Latest Updated Articles
- Denosumab Increase Bone Mineral Density in Men Receiving Androgen-Deprivation Therapy
Published: August 17th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
House Votes to Extend ACA Subsidies, Eyes Turn to Senate
2
5 Key Health Care Changes During Trump’s First Year Back in Office
3
Redefining Oncology Through the Academic-Community Dyad Model
4
Disparities Drive Shifting Pancreatic Cancer Survival Trends
5
